Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zepatier for 8 weeks in treatment-naïve HCV GT4
NCT03578640Phase 3Completed
- Sponsor
- King Fahd Medical City
- Start
- Jul 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of grazoprevir in hepatitis C virus infection, sponsored by King Fahd Medical City. Started Jul 2018; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03578640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03578640.